Monday December 18th 2017

Good Cardiac Safety In Patients With Relapsing Remitting Multiple Sclerosis Upon First Fingolimod Dose (P2.197)

CONCLUSIONS: This national study confirms the good cardiac safety profile of fingolimod, which has already been documented in the previous pivotal multicenter trials, leading to approval. Additionally, the possible impact of co-medication on AV-conduction, relevant for sub-groups of RRMS patients, is addressed. Study Supported by: Novartis Pharma GbmHDisclosure: Dr. Limmroth has received personal compensation or research support for activities with Bayer Pharmaceuticals Inc., Biogen Idec, Novartis, Roche Diagnostics Corp., Sanofi-Aventis Pharmaceuticals Inc., Serono Inc., and Teva Neuroscience. Dr. Hoyer has received personal compensation for activities with Novartis. Dr. Schmidt has received personal compensation for activities with Bayer Pharmaceuticals Corp., Biogen Idec, Merck Serono, …

Continue reading¬†–¬†

Good Cardiac Safety In Patients With Relapsing Remitting Multiple Sclerosis Upon First Fingolimod Dose (P2.197)

Leave a Comment

More from category

MS Activists Celebrate 2017 State Policy Impact
MS Activists Celebrate 2017 State Policy Impact

/About-the-Society/News/MS-Activists-Celebrate-2017-State-Policy-Impact [Read More]

MS Research Program Funding Authorized by President Trump
MS Research Program Funding Authorized by President Trump

/About-the-Society/News/MS-Research-Program-Funding-Authorized-by-Presiden [Read More]

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]